The diabetic foot ulcers therapeutics market is expected to maintain a moderate growth over the coming years, having increased from a market value of £1.13 billion in 2006, to reach $1.53 billion by 2011. By 2019 it is predicted that the diabetic foot ulcers market will continue this growth and will hit a market value of $1.97 billion.
Diabetic foot ulcers can drastically impair quality of life and are a cause of significant morbidity, accounting for 20% of all diabetes-related hospital admissions in the US.
The diabetic foot ulcers market is made up of the diabetic foot infection (DFI) and wound healing sectors, with the two experiencing differing fortunes within the market.
On one hand the diabetic foot infection market experienced a positive growth, climbing from $1 billion to reach $1.6 billion, but the wound healing sector experienced a very different fate.
The wound healing market dropped from $126.5m in 2006, to $73.8m in 2011, dropping at a negative compound annual growth rate (CAGR) of 10.2%. This market decline can be attributed to the fact that the US Food and Drugs Administration (FDA) slapped a 'black box' warning on their only product, Regranex, due to concerns that large quantities could increase the risk of cancer by up to five times.
None the less, the DFI sector was also not without its woes. The three major drugs in this area all have side effect issues. Given the problems with these current treatments, it appears there are opportunities for new drugs to push through and make an impression on the diabetic foot ulcers therapeutics market.
For more information on the diabetic foot ulcers therapeutics market, see the latest research: Diabetic Foot Ulcers Therapeutics Market Report
Follow us on Twitter @CandMResearch
Companiesandmarkets.com issues news updates and report summaries covering all major industries and sectors. The service provides additional client monitoring and timely alerts to breaking industry and sector news leading the day's business headlines. News articles, written by our staff, contain additional analyst insight, providing value added insight for our readers. News updates and real-time alerts on newly-released market reports are also available from our Facebook page, Twitter feed @CandMResearch and RSS links. We also welcome inquiries from business journalists and the news media.